methyldopa has been researched along with prednisolone in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (29.41) | 18.7374 |
| 1990's | 2 (11.76) | 18.2507 |
| 2000's | 4 (23.53) | 29.6817 |
| 2010's | 6 (35.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Fujimura, M; Funada, H; Harada, M; Koshino, T; Matsuda, T; Nakamura, S; Otake, S; Otsuka, M; Ueda, M | 1 |
| Bessler, H; Djaldetti, M; Lewinski, U; Mandel, EM | 1 |
| Drozdova, GA; Frolov, VA; Kazanskaia, TA; Kiseleva, NP; Paukov, VS | 1 |
| Fukui, Y; Shiozaki, Y | 1 |
| Akiba, T; Hayama, S; Kurihara, R; Matsunobu, S; Osono, E; Owada, K; Sakurai, Y; Suga, S; Takeuchi, M; Yoneshima, H | 1 |
| Queiro, R; Riestra, JL; Weruaga, A | 1 |
| KAHLSON, G; ROSENGREN, E; THUNBERG, R | 1 |
| ATARASHI, J; YOSHIMURA, M | 1 |
| Basgul, A; Cakalagaoglu, F; Gokaslan, H; Kavak, ZN; Sezen, D | 1 |
4 review(s) available for methyldopa and prednisolone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Recent status in drug-induced pancreatitis].
Topics: Cyclosporins; Female; Humans; Japan; Male; Methyldopa; Pancreatitis; Prednisolone; Prognosis | 1994 |
[A case of SLE-like syndrome and severe hemolytic anemia caused by methyldopa].
Topics: Anemia, Hemolytic, Autoimmune; Humans; Immunosorbent Techniques; Lupus Erythematosus, Systemic; Male; Methyldopa; Middle Aged; Plasma Exchange; Prednisolone | 1995 |
[GENERAL PRINCIPLES IN THE DRUG THERAPY OF CEREBROVASCULAR DISORDERS].
Topics: Adenosine Triphosphate; Adrenal Cortex Hormones; Antihypertensive Agents; Blood Circulation; Cerebrovascular Disorders; Chlorothiazide; Cytochromes; Humans; Hydralazine; Kallikreins; Methyldopa; Monoamine Oxidase Inhibitors; Niacin; Prednisolone; Reserpine; Vasodilator Agents | 1964 |
13 other study(ies) available for methyldopa and prednisolone
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
[A case of autoimmune hemolytic anemia, interstitial pneumonia and liver injury occurred during one month's medication of small dose of alpha-methyldopa].
Topics: Aged; Anemia, Hemolytic, Autoimmune; Chemical and Drug Induced Liver Injury; Humans; Male; Methyldopa; Prednisolone; Pulmonary Fibrosis | 1985 |
Inhibition of uridine incorporation in proerythroblasts patients with alpha-methyldopa induced haemolytic anaemia.
Topics: Anemia, Hemolytic; Animals; Autoradiography; Coombs Test; Erythrocytes; Female; Hematopoietic Stem Cells; Hemoglobins; Humans; Hydrazines; Hypertension; Injections, Intraperitoneal; Male; Methyldopa; Mice; Middle Aged; Osmotic Fragility; Prednisolone; Reticulocytes; Thymidine; Tritium; Uridine | 1974 |
[Some general regularities of pathological processes in the heart].
Topics: Animals; Cytoplasmic Granules; Dinitrophenols; Diphtheria Toxin; Dogs; Endoplasmic Reticulum; Glycosides; Heart; Heart Diseases; Histocytochemistry; Hyperthyroidism; Lipids; Methyldopa; Microscopy, Electron; Mitochondria, Muscle; Myocardium; Myofibrils; Pituitary Hormones, Posterior; Prednisolone; Rabbits | 1971 |
C4 deficiency state in antiphospholipid antibody-related recurrent preeclampsia evolving into systemic lupus erythematosus.
Topics: Adult; Anti-Inflammatory Agents; Antiphospholipid Syndrome; Complement C4; Drug Therapy, Combination; Female; Genetic Predisposition to Disease; Humans; Lupus Erythematosus, Systemic; Methyldopa; Pre-Eclampsia; Prednisolone; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Treatment Outcome | 2002 |
OBSERVATIONS ON THE INHIBITION OF HISTAMINE FORMATION.
Topics: Anti-Allergic Agents; Carbon Isotopes; Carboxy-Lyases; Chromatography; Cortisone; Enzyme Inhibitors; Gastric Juice; Histamine; Histamine H1 Antagonists; Histidine; Hydrazines; Mast Cells; Methyldopa; Physiology; Prednisolone; Pyridoxal Phosphate; Pyridoxine; Rats; Research; Urine | 1963 |
A rare case of early onset nephrotic syndrome in pregnancy.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diet, Sodium-Restricted; Female; Fetal Death; Glucocorticoids; Humans; Hypertension, Pregnancy-Induced; Kidney; Methyldopa; Nephrotic Syndrome; Prednisolone; Pregnancy; Pregnancy Complications | 2006 |